EGFR and breast carcinoma: Nucleic acid aptamers that can recognize specific target molecules are used to increase the specificity of targeting the PSMA aptamer in prostate cancer xenografts, EGFR aptamer in breast cancer xenografts, and survivin in colorectal cancer xenografts [329].